Securities code: Bloomage Biotechnology Corporation Limited(688363) securities abbreviation: Bloomage Biotechnology Corporation Limited(688363) Announcement No.: 2022005 Bloomage Biotechnology Corporation Limited(688363)
Announcement of annual profit distribution plan in 2021
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal responsibility for the authenticity, accuracy and completeness of its contents.
Important content tips:
Distribution ratio per share: cash dividend of 0.49 yuan (tax included) per share will be distributed, capital reserve will not be converted into share capital, and bonus shares will not be distributed.
The profit distribution is based on the total share capital registered on the equity distribution registration date, and the specific date will be specified in the equity distribution implementation announcement.
If the total share capital of the company changes before the equity registration date of equity distribution, it is proposed to maintain the distribution proportion per share unchanged and adjust the total distribution accordingly. 1、 Contents of profit distribution plan
According to the audit of Zhitong Certified Public Accountants (special general partnership), the net profit attributable to the shareholders of the parent company in the consolidated statements of 2021 is 78233457348 yuan, the net profit after tax of the parent company is 99774528598 yuan, and the distributable profit of the parent company in 2021 is 161373765512 yuan after the statutory reserve of 9977452860 yuan is withdrawn according to 10% of the net profit after tax of the parent company. According to the resolution of the board of directors, the company plans to distribute profits based on the total share capital registered on the date of equity distribution in 2021. The profit distribution plan is as follows:
The listed company plans to distribute a cash dividend of 4.90 yuan (including tax) to all shareholders for every 10 shares. As of December 31, 2021, the total share capital of the company is 480000000 shares. Based on this calculation, the total cash dividend to be distributed is 23520000000 yuan (including tax). The total cash dividends of the company in this year accounted for 30.06% of the net profit attributable to the shareholders of the parent company in the consolidated statements.
The 29th meeting of the first board of directors of the company has approved the company’s restricted stock incentive plan in 2021, and the vesting conditions specified in the first vesting period for the first time have been achieved. The number of restricted shares that can be vested this time is 1085277, For details, please refer to the announcement that the first vesting period of Bloomage Biotechnology Corporation Limited(688363) 2021 restricted stock incentive plan meets the vesting conditions for the first time (Announcement No.: 2022011) disclosed by the company in Shanghai Stock Exchange on March 11, 2022. If these shares are vested and listed before the equity distribution registration date, the total share capital of the company will be changed to 481085277 shares. Based on this calculation, the total cash dividend to be distributed is 23573178573 yuan (including tax), accounting for 30.13% of the net profit attributable to the shareholders of the parent company in the consolidated statements.
If the total share capital of the company changes from the date of disclosure of this announcement to the date of equity distribution and equity registration due to the conversion of convertible bonds into shares / share repurchase / share incentive grant share repurchase and cancellation / major asset restructuring share repurchase and cancellation, the company plans to maintain the distribution proportion per share unchanged and adjust the total distribution accordingly.
The profit distribution plan needs to be submitted to the general meeting of shareholders for deliberation. 2、 Decision making procedures performed by the company (I) convening, deliberation and voting of the board meeting
The company held the 29th meeting of the first board of directors on March 10, 2022, and deliberated and adopted the proposal on the company’s profit distribution plan for 2021, which needs to be submitted to the general meeting of shareholders for deliberation. （2） Opinions of independent directors
The profit distribution plan for 2021 is formulated in accordance with the company’s dividend return plan for the next three years (20192021), comprehensively considering the company’s operating conditions, capital needs, future development and other factors, and with reference to the self regulatory guidelines for companies listed on the science and Innovation Board of Shanghai Stock Exchange No. 1 – standardized operation, At the same time, considering the arrangement of the first vesting period of the company’s restricted stock incentive plan for the first time in 2021, if the total share capital of the company changes before the equity registration date of equity distribution, it is proposed to maintain the amount of cash dividend distributed per share unchanged and adjust the total amount of distribution accordingly, which is in line with the interests of the company and all shareholders. The independent directors unanimously agree on the profit distribution plan. （3） Opinions of the board of supervisors
The company held the 24th Meeting of the first board of supervisors on March 10, 2022, deliberated and adopted the proposal on the company’s profit distribution plan in 2021. The board of supervisors believes that the company’s annual profit distribution plan for 2021 is based on the company’s dividend return plan for the next three years (20192021), and takes full account of the company’s profitability, cash flow status, capital demand and other factors. It does not harm the interests of minority shareholders, which is in line with the current operation situation of the company and conducive to the sustainable, stable and healthy development of the company. Agree to this profit distribution plan and submit it to the 2021 annual general meeting of shareholders of the company for deliberation. 3、 Relevant risk tips (I) analysis of the impact of cash dividends on earnings per share, cash flow status and production and operation of listed companies
This profit distribution plan comprehensively considers the company’s development stage, future capital demand and other factors, and will not have a significant impact on the company’s operating cash flow, normal operation and long-term development of the company. （2） Description of other risks
This profit distribution plan must be submitted to the company’s 2021 annual general meeting for deliberation and approval. Please pay attention to the investment risks.
It is hereby announced.
Bloomage Biotechnology Corporation Limited(688363) board of directors March 11, 2021
